4.7 Letter

DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Role of HSP90 in Cancer

Bereket Birbo et al.

Summary: HSP90 is a crucial chaperone protein with different isoforms present in various cell compartments. Elevated levels of HSP90 have been linked to cancer, making it a target for cancer drugs. Differences in conformation between normal HSP90 and tumor phenotype HSP90 have led to the development of HSP90 inhibitors as a potential cancer treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cell Biology

Extracellular HSP90 Machineries Build Tumor Microenvironment and Boost Cancer Progression

Pietro Poggio et al.

Summary: Extracellular HSP90 complexes released by cancer cells in the tumor microenvironment play essential roles in tumor growth and progression, highlighting their potential as targets for innovative diagnostic tools and therapies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Pharmacology & Pharmacy

Recent Advances in the Discovery of Novel HSP90 Inhibitors: An Update from 2014

Yan Xiao et al.

CURRENT DRUG TARGETS (2020)

Review Biochemical Research Methods

Advances in Antibody-Drug Conjugate Design: Current Clinical Landscape and Future Innovations

Laurence Gauzy-Lazo et al.

SLAS DISCOVERY (2020)

Review Biochemistry & Molecular Biology

Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy

Hao Chen et al.

MOLECULES (2017)

Review Oncology

Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate

Marco Corazzari et al.

FRONTIERS IN ONCOLOGY (2017)

Review Oncology

To wake up cancer stem cells, or to let them sleep, that is the question

Shoichiro Takeishi et al.

CANCER SCIENCE (2016)

Review Biochemistry & Molecular Biology

Secreted heat shock protein-90 (Hsp90) in wound healing and cancer

Wei Li et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)